National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 398145

History of Changes from the VAERS Wayback Machine

First Appeared on 9/22/2010

VAERS ID: 398145
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2009-10-14
Onset:0000-00-00
Submitted:2010-09-13
Entered:2010-09-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Encephalitis

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1009USA00838

Write-up:Information has been received from a Health Authority (reference # ADR20657398) concerning a 13 year old female patient with unreported medical history who on 14-OCT-2009 was vaccinated intramuscularly with the first dose of GARDASIL (manufacturer, batch # not reported and site not reported). On 13-NOV-2009, the patient was vaccinated intramuscularly with the second dose of GARDASIL (manufacturer, batch # not reported and site not reported) and experienced N-Methyl-D-Aspartate Receptor (NDA) encephalitis and was hospitalized. On an unreported date, the patient became symptomatic either in the same month as the patient received the first dose and onwards or three days prior to admission to the hospital. The patient was confirmed to have N-Methyl-D-Aspartate Receptor (NDA) encephalitis. A third dose of GARDASIL was not given. The patient was recovering at the time of reporting. According to the reporter and the agency the event was considered serious as it was life-threatening, hospitalization and disabling/incapacity. The agency coded the event of encephalitis. This case is medically confirmed. Other business partner numbers include E2010-05321. No further information is available.


Changed on 2/13/2013

VAERS ID: 398145 Before After
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2009-10-14
Onset:0000-00-00
Submitted:2010-09-13
Entered:2010-09-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Encephalitis

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0 (blank)     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1009USA00838

Write-up:Information has been received from a Health Authority (reference # ADR20657398) concerning a 13 year old female patient with unreported medical history who on 14-OCT-2009 was vaccinated intramuscularly with the first dose of GARDASIL (manufacturer, batch # not reported and site not reported). On 13-NOV-2009, the patient was vaccinated intramuscularly with the second dose of GARDASIL (manufacturer, batch # not reported and site not reported) and experienced N-Methyl-D-Aspartate Receptor (NDA) encephalitis and was hospitalized. On an unreported date, the patient became symptomatic either in the same month as the patient received the first dose and onwards or three days prior to admission to the hospital. The patient was confirmed to have N-Methyl-D-Aspartate Receptor (NDA) encephalitis. A third dose of GARDASIL was not given. The patient was recovering at the time of reporting. According to the reporter and the agency the event was considered serious as it was life-threatening, hospitalization and disabling/incapacity. The agency coded the event of encephalitis. This case is medically confirmed. Other business partner numbers include E2010-05321. No further information is available.


Changed on 6/14/2014

VAERS ID: 398145 Before After
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2009-10-14
Onset:0000-00-00
Submitted:2010-09-13
Entered:2010-09-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Encephalitis

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1009USA00838

Write-up:Information has been received from a Health Authority (reference # ADR20657398) concerning a 13 year old female patient with unreported medical history who on 14-OCT-2009 was vaccinated intramuscularly with the first dose of GARDASIL (manufacturer, batch # not reported and site not reported). On 13-NOV-2009, the patient was vaccinated intramuscularly with the second dose of GARDASIL (manufacturer, batch # not reported and site not reported) and experienced N-Methyl-D-Aspartate Receptor (NDA) encephalitis and was hospitalized. On an unreported date, the patient became symptomatic either in the same month as the patient received the first dose and onwards or three days prior to admission to the hospital. The patient was confirmed to have N-Methyl-D-Aspartate Receptor (NDA) encephalitis. A third dose of GARDASIL was not given. The patient was recovering at the time of reporting. According to the reporter and the agency the event was considered serious as it was life-threatening, hospitalization and disabling/incapacity. The agency coded the event of encephalitis. This case is medically confirmed. Other business partner numbers include E2010-05321. No further information is available.


Changed on 3/14/2015

VAERS ID: 398145 Before After
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2009-10-14
Onset:0000-00-00
Submitted:2010-09-13
Entered:2010-09-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Encephalitis

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1009USA00838

Write-up:Information has been received from a Health Authority (reference # ADR20657398) concerning a 13 year old female patient with unreported medical history who on 14-OCT-2009 was vaccinated intramuscularly with the first dose of GARDASIL (manufacturer, batch # not reported and site not reported). On 13-NOV-2009, the patient was vaccinated intramuscularly with the second dose of GARDASIL (manufacturer, batch # not reported and site not reported) and experienced N-Methyl-D-Aspartate Receptor (NDA) encephalitis and was hospitalized. On an unreported date, the patient became symptomatic either in the same month as the patient received the first dose and onwards or three days prior to admission to the hospital. The patient was confirmed to have N-Methyl-D-Aspartate Receptor (NDA) encephalitis. A third dose of GARDASIL was not given. The patient was recovering at the time of reporting. According to the reporter and the agency the event was considered serious as it was life-threatening, hospitalization and disabling/incapacity. The agency coded the event of encephalitis. This case is medically confirmed. Other business partner numbers include E2010-05321. No further information is available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=398145&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166